Neogen Corporation Goodwill, Translation and Purchase Accounting Adjustments
Neogen Corporation (NEOG) reported Goodwill, Translation and Purchase Accounting Adjustments of -$17.70 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2026-07-30
- Neogen Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2025-05-31 was -$9.55M.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2025-02-28 was -$796.00K.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2024-05-31 was -$706.00K, a 114.58% decline year-over-year.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2024-02-29 was -$1.65M.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for fiscal 2026 was -$17.70M.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for fiscal 2025 was -$12.30M.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for fiscal 2024 was -$2.11M, a 183.46% decline from fiscal 2023.
- Neogen Corporation goodwill, translation and purchase accounting adjustments for fiscal 2023 was $2.53M.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 3 month | Goodwill, Translation and Purchase Accounting Adjustments 6 month | Goodwill, Translation and Purchase Accounting Adjustments 9 month | Goodwill, Translation and Purchase Accounting Adjustments 12 month | Goodwill, Translation and Purchase Accounting Adjustments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | -$17.70M 10-K · filed 2026-07-30 | ||||
| 2025-05-31 | -$9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$10.34M derived: sum of 2 quarters · filed 2026-07-30 | -$12.30M 10-K · filed 2026-07-30 | -$12.30M 10-K · filed 2025-07-30 | |
| 2025-02-28 | -$796.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | -$2.75M 10-Q · filed 2025-04-09 | |||
| 2024-11-30 | -$1.96M 10-Q · filed 2025-01-15 | ||||
| 2024-05-31 | -$706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | -$2.35M derived: sum of 2 quarters · filed 2025-07-30 | -$1.97M derived: sum of 3 quarters · filed 2025-07-30 | -$2.11M 10-K · filed 2025-07-30 | |
| 2024-02-29 | -$1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$1.26M derived: sum of 2 quarters · filed 2024-04-09 | -$1.41M 10-Q · filed 2024-04-09 | $3.44M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-11-30 | $381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $237.00K 10-Q · filed 2024-01-09 | $5.08M derived: sum of 3 quarters · filed 2024-07-30 | -$13.00M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-08-31 | -$144.00K 10-Q · filed 2023-10-10 | $4.70M derived: sum of 2 quarters · filed 2024-07-30 | -$13.38M derived: sum of 3 quarters · filed 2024-07-30 | ||
| 2023-05-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$13.23M derived: sum of 2 quarters · filed 2024-07-30 | $2.53M 10-K · filed 2024-07-30 | ||
| 2023-02-28 | -$18.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | -$2.31M 10-Q · filed 2023-04-04 | |||
| 2022-11-30 | $15.77M 10-Q · filed 2023-01-09 | ||||
| 2022-05-31 | -$4.68M 10-K · filed 2023-08-15 | ||||
| 2021-05-31 | $2.36M 10-K · filed 2022-07-27 | ||||
| 2020-05-31 | -$1.63M 10-K · filed 2021-07-30 | ||||
| 2019-05-31 | -$931.00K 10-K · filed 2020-07-30 | ||||
| 2018-05-31 | -$5.96M 10-K · filed 2019-07-30 | ||||
| 2017-05-31 | -$2.80M 10-K · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |